Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$12.73
-1.05%
Mkt Cap $915.30M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
Implied Upside
+198.6%
Consensus $38.00 vs current $12.73
NASDAQ·Healthcare·Biotechnology
$12.73
-1.05%
Mkt Cap $915.30M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
+198.6%
Consensus $38.00 vs current $12.73